TipRanks
Go Ultimate55% OFF

Protara Therapeutics (TARA) Ownership - Who Owns Protara Therapeutics?

Protara Therapeutics (TARA) Ownership Overview

  • 2.84% Insiders
  • 9.11% Mutual Funds
  • 0.09% Other Institutional Investors
  • 9.67% ETFs
  • 78.30% Public Companies and Individual Investors

The ownership structure of Protara Therapeutics (TARA) stock is a mix of institutional, retail, and individual investors. Approximately 18.86% of the company’s stock is owned by Institutional Investors, 2.84% is owned by Insiders, and 78.30% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Recent Insider Trading Activity
DateNameActivityValue
Jun 30, 2026Jesse Shefferman$882,160

Recent Hedge Fund Trading Activity

Recent Hedge Fund Trading Activity
DateFirmActivityValue
Jun 30, 2026Fisher Asset Management Llc$380,342
Jun 30, 2026Entrypoint Capital, Llc$73,673
Jun 30, 2026 $13,994,566

Top Shareholders

TARA top shareholders
Holder# of SharesType% HoldingValue
Vanguard2,608,624Institution4.41%6,469,388
Stephen A. Schwarzman2,265,514Institution3.83%5,618,475
Vanguard Index Funds2,244,844Institution3.80%5,567,213
Ishares2,006,231Institution3.39%4,975,453
Steve Weber1,259,427Institution2.13%3,123,379
Jesse Shefferman991,832Insider1.68%2,459,743
Felix Baker971,614Institution1.64%2,409,603
Columbia Funds Series Trust I769,426Institution1.30%1,908,176
Fidelity Salem Street Trust650,389Institution1.10%1,612,965
Fidelity Concord Street Trust465,314Institution0.79%1,153,979

Top Mutual Fund Holders

TARA top mutual fund holders
Holder# of SharesType% HoldingValue
Vanguard Index Funds2,244,844Institution3.80%5,567,213
Columbia Funds Series Trust I769,426Institution1.30%1,908,176
Fidelity Salem Street Trust650,389Institution1.10%1,612,965
Fidelity Concord Street Trust465,314Institution0.79%1,153,979
Dfa Investment Dimensions Group Inc362,410Institution0.61%898,777
Vanguard Scottsdale Funds350,941Institution0.59%870,334
Schwab Capital Trust157,956Institution0.27%391,731
Bridgeway Funds, Inc.78,000Institution0.13%193,440
Tiaa-cref Funds70,086Institution0.12%173,813
Goldman Sachs Trust37,784Institution0.06%93,704

Top ETF Holders

TARA top ETF holders
Holder# of SharesType% HoldingValue
Vanguard1,657,879Institution2.81%5,056,531
iShares1,339,571Institution2.27%3,375,719
Vanguard586,965Institution0.99%1,790,243
iShares511,355Institution0.87%1,288,615
DFA393,668Institution0.67%992,043
Vanguard312,192Institution0.53%952,186
iShares160,159Institution0.27%403,601
Dimensional131,860Institution0.22%516,891
SPDR114,070Institution0.19%287,456
Avantis94,616Institution0.16%238,432

FAQ

Who Owns Protara Therapeutics (TARA)?
According to the latest TipRanks data, approximately 0.09% of the company's stock is held by institutional investors, 2.84% is held by insiders, and 78.30% is held by retail investors.
What percentage of Protara Therapeutics (TARA) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.09% of Protara Therapeutics (TARA) stock is held by institutional investors.
What percentage of Protara Therapeutics (TARA) stock is held by retail investors?
According to the latest TipRanks data, approximately 78.30% of Protara Therapeutics (TARA) stock is held by retail investors.
Who owns the most shares of Protara Therapeutics (TARA)?
Vanguard owns the most shares of Protara Therapeutics (TARA).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.